FDA Looking Into New Review Process for Opioids, Gottlieb Says

Drug Industry Daily
A A
FDA Commissioner Scott Gottlieb says the agency is mulling a fresh way of reviewing new opioid drugs before approving them.

To View This Article:

Login

Subscribe To Drug Industry Daily